Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness (vol 300, pg 594, 2021)

被引：0
|
作者：
Kang, Stella K.
Mali, Rahul D.
Prabhu, Vinay
Ferket, Bart S.
Loeb, Stacy
机构：
来源：
RADIOLOGY | 2021年 / 301卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis (vol 198, pg 546, 2013)
    Martin, Andrew J.
    MEDICAL JOURNAL OF AUSTRALIA, 2014, 200 (04) : 205 - 205
  • [32] Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach
    Guidotti, Alessio
    Lombardo, Riccardo
    De Nunzio, Cosimo
    JOURNAL OF UROLOGY, 2023, 209 (06): : 1107 - 1108
  • [33] Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach
    Timilshina, N.
    Alibhai, S. M. H.
    Tomlinson, G.
    Sander, B.
    Cheung, D. C.
    Finelli, A.
    JOURNAL OF UROLOGY, 2023, 209 (03): : 540 - 548
  • [34] INCORPORATING THE PRECISE RECOMMENDATIONS TO EVALUATE PROGRESSION IN MEN ON ACTIVE SURVEILLANCE FOR LOW-GRADE PROSTATE CANCER: WHICH PATIENTS WITH LOW PRECISE SCORE NEED A CONFIRMATORY BIOPSY?
    Leni, Riccardo
    Gandaglia, Giorgio
    Stabile, Armando
    Cucchiara, Vito
    Mazzone, Elio
    Rosiello, Giuseppe
    Robesti, Daniele
    Pellegrino, Antony
    Longoni, Mattia
    Scilipoti, Pietro
    Zaffuto, Emanuele
    De Cobelli, Francesco
    Giorgio, Brembilla
    Giganti, Francesco
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2023, 209 : E531 - E532
  • [35] Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer (vol 304, pg 2373, 2010)
    Hayes, J. H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (18): : 1862 - 1862
  • [36] Cost-effectiveness and budget impact of lung cancer immunotherapy in South America: strategies to improve access (vol 10, pg 887, 2018)
    Aguiar, Pedro, Jr.
    Del Giglio, Auro
    Perry, Luke Alastair
    Penny-Dimri, Jahan
    Babiker, Hani
    Tadokoro, Hakaru
    Lopes, Gilberto, Jr.
    De Mello, Ramon Andrade
    IMMUNOTHERAPY, 2018, 10 (14) : 1285 - 1285
  • [37] Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10 years
    Leclercq, L.
    Bastide, C.
    Lechevallier, E.
    Walz, J.
    Charvet, A. -L.
    Gondran-Tellier, B.
    Campagna, J.
    Savoie, P. -Henri
    Long-Depaquit, T.
    Daniel, L.
    Rossi, D.
    Pignot, G.
    Baboudjian, M.
    FRENCH JOURNAL OF UROLOGY, 2024, 34 (02):
  • [38] Is Active Surveillance an Option for the Management of Men with Low-grade Prostate Cancer and a Positive Family History? Results from a Large, Single-institution Series
    Leni, Riccardo
    Gandaglia, Giorgio
    Stabile, Armando
    Mazzone, Elio
    Pellegrino, Francesco
    Scuderi, Simone
    Robesti, Daniele
    Barletta, Francesco
    Cirulli, Giuseppe Ottone
    Cucchiara, Vito
    Zattuto, Emanuele
    Deho, Federico
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (05): : 493 - 500
  • [39] Estimated Quality of Life and Economic Outcomes Associated With 12 Cervical Cancer Screening Strategies: A Cost-effectiveness Analysis (vol 179, pg 867, 2019)
    Sawaya, G. F.
    Sanstead, E.
    Alarid-Escudero, F.
    JAMA INTERNAL MEDICINE, 2019, 179 (08) : 1152 - 1152
  • [40] Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness (vol 10, pg 267, 2012)
    Goulart
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (12): : LVI - LVI
12345